Pricing Log in Create free account

Alvotech (ALVO) vs Regencell Bioscience Holdings Limited (RGC)

Alvotech and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $2.6B against $1.8B — 1.5× the size. Regencell Bioscience Holdings Limited has the higher net margin (0.00% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, Regencell Bioscience Holdings Limited leads on 5 and Alvotech on 2.

Valuation

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.60 — 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 1.13 12.22
EV/Sales 8.56 n/m 2.87
Earnings yield (26.12%) (19.96%) (15.94%)
Free cash flow yield (15.71%) 0.00% 0.00%

Profitability

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
Gross margin 42.71% — 53.51%
Operating margin (42.43%) — 0.00%
Net margin (101.05%) 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% — 5.22%
EPS growth (last fiscal year) 111.49% (177.78%) 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.00 0.04
Current ratio 1.65 10.77 2.41
Net debt to EBITDA 9.71 1.22 1.01

Dividend

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ALVO RGC Drug Manufacturers Specialty & Generic median
Market cap 1.78b 2.61b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack